Renal safety of tenofovir in HIV-infected children

A prospective, 96-week longitudinal study

A. Viganò, G. V. Zuccotti, L. Martelli, V. Giacomet, L. Cafarelli, S. Borgonovo, S. Beretta, G. Rombolà, S. Mora

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Background: The renal safety of tenofovir in HIV-infected children has not been well studied. In paediatrics, prediction of glomerular filtration rate (GFR) is usually obtained by the Schwartz equation; the Cockcroft-Gault equation is considered more appropriate in children aged >12 years, but can be misleading in younger children. The aims of this study were to assess renal safety and GFR changes as estimated by the Schwartz and Cockcroft-Gault equations in HIV-infected children treated with tenofovir for 96 weeks. Methods: Several parameters of glomerular and tubular function were prospectively assessed (at baseline and at weeks 24, 48, 72 and 96) in 27 HIV-infected children (aged 4.9-18.0 years) receiving a tenofovir-containing antiretroviral regimen. GFR was estimated using Schwartz and Cockcroft-Gault equations in children younger and older than 12 years, respectively. Results: No child experienced a grade 1 (≥44 μmol/L) or higher increase in serum creatinine or a grade 1 (≤0.71 mmol/L) or higher hypophosphataemia. Serum bicarbonate values were in the normal range for age at baseline. Mean serum creatinine, serum phosphorus and serum bicarbonate values remained unchanged. No child showed proteinuria, microalbuminuria or glycosuria at baseline or during the study period. The mean urinary protein/creatinine, albumin/creatinine, α1-microglobulin/creatinine and maximal tubular phosphate reabsorption (TmPO4/GFR) ratios remained unchanged. Up to week 96, no patient experienced a significant decrease in GFR, as estimated by the more appropriate formula for age. Conclusion: Through 96 weeks, we found no evidence of impaired glomerular or tubular renal function in tenofovir-treated HIV-infected children.

Original languageEnglish
Pages (from-to)573-581
Number of pages9
JournalClinical Drug Investigation
Volume27
Issue number8
DOIs
Publication statusPublished - 2007

Fingerprint

Tenofovir
Longitudinal Studies
HIV
Kidney
Safety
Glomerular Filtration Rate
Creatinine
Serum
Bicarbonates
Glycosuria

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Renal safety of tenofovir in HIV-infected children : A prospective, 96-week longitudinal study. / Viganò, A.; Zuccotti, G. V.; Martelli, L.; Giacomet, V.; Cafarelli, L.; Borgonovo, S.; Beretta, S.; Rombolà, G.; Mora, S.

In: Clinical Drug Investigation, Vol. 27, No. 8, 2007, p. 573-581.

Research output: Contribution to journalArticle

Viganò, A, Zuccotti, GV, Martelli, L, Giacomet, V, Cafarelli, L, Borgonovo, S, Beretta, S, Rombolà, G & Mora, S 2007, 'Renal safety of tenofovir in HIV-infected children: A prospective, 96-week longitudinal study', Clinical Drug Investigation, vol. 27, no. 8, pp. 573-581. https://doi.org/10.2165/00044011-200727080-00006
Viganò, A. ; Zuccotti, G. V. ; Martelli, L. ; Giacomet, V. ; Cafarelli, L. ; Borgonovo, S. ; Beretta, S. ; Rombolà, G. ; Mora, S. / Renal safety of tenofovir in HIV-infected children : A prospective, 96-week longitudinal study. In: Clinical Drug Investigation. 2007 ; Vol. 27, No. 8. pp. 573-581.
@article{b6fe04ddd91c4cecb2bd7760bc12d4f4,
title = "Renal safety of tenofovir in HIV-infected children: A prospective, 96-week longitudinal study",
abstract = "Background: The renal safety of tenofovir in HIV-infected children has not been well studied. In paediatrics, prediction of glomerular filtration rate (GFR) is usually obtained by the Schwartz equation; the Cockcroft-Gault equation is considered more appropriate in children aged >12 years, but can be misleading in younger children. The aims of this study were to assess renal safety and GFR changes as estimated by the Schwartz and Cockcroft-Gault equations in HIV-infected children treated with tenofovir for 96 weeks. Methods: Several parameters of glomerular and tubular function were prospectively assessed (at baseline and at weeks 24, 48, 72 and 96) in 27 HIV-infected children (aged 4.9-18.0 years) receiving a tenofovir-containing antiretroviral regimen. GFR was estimated using Schwartz and Cockcroft-Gault equations in children younger and older than 12 years, respectively. Results: No child experienced a grade 1 (≥44 μmol/L) or higher increase in serum creatinine or a grade 1 (≤0.71 mmol/L) or higher hypophosphataemia. Serum bicarbonate values were in the normal range for age at baseline. Mean serum creatinine, serum phosphorus and serum bicarbonate values remained unchanged. No child showed proteinuria, microalbuminuria or glycosuria at baseline or during the study period. The mean urinary protein/creatinine, albumin/creatinine, α1-microglobulin/creatinine and maximal tubular phosphate reabsorption (TmPO4/GFR) ratios remained unchanged. Up to week 96, no patient experienced a significant decrease in GFR, as estimated by the more appropriate formula for age. Conclusion: Through 96 weeks, we found no evidence of impaired glomerular or tubular renal function in tenofovir-treated HIV-infected children.",
author = "A. Vigan{\`o} and Zuccotti, {G. V.} and L. Martelli and V. Giacomet and L. Cafarelli and S. Borgonovo and S. Beretta and G. Rombol{\`a} and S. Mora",
year = "2007",
doi = "10.2165/00044011-200727080-00006",
language = "English",
volume = "27",
pages = "573--581",
journal = "Clinical Drug Investigation",
issn = "1173-2563",
publisher = "Adis International Ltd",
number = "8",

}

TY - JOUR

T1 - Renal safety of tenofovir in HIV-infected children

T2 - A prospective, 96-week longitudinal study

AU - Viganò, A.

AU - Zuccotti, G. V.

AU - Martelli, L.

AU - Giacomet, V.

AU - Cafarelli, L.

AU - Borgonovo, S.

AU - Beretta, S.

AU - Rombolà, G.

AU - Mora, S.

PY - 2007

Y1 - 2007

N2 - Background: The renal safety of tenofovir in HIV-infected children has not been well studied. In paediatrics, prediction of glomerular filtration rate (GFR) is usually obtained by the Schwartz equation; the Cockcroft-Gault equation is considered more appropriate in children aged >12 years, but can be misleading in younger children. The aims of this study were to assess renal safety and GFR changes as estimated by the Schwartz and Cockcroft-Gault equations in HIV-infected children treated with tenofovir for 96 weeks. Methods: Several parameters of glomerular and tubular function were prospectively assessed (at baseline and at weeks 24, 48, 72 and 96) in 27 HIV-infected children (aged 4.9-18.0 years) receiving a tenofovir-containing antiretroviral regimen. GFR was estimated using Schwartz and Cockcroft-Gault equations in children younger and older than 12 years, respectively. Results: No child experienced a grade 1 (≥44 μmol/L) or higher increase in serum creatinine or a grade 1 (≤0.71 mmol/L) or higher hypophosphataemia. Serum bicarbonate values were in the normal range for age at baseline. Mean serum creatinine, serum phosphorus and serum bicarbonate values remained unchanged. No child showed proteinuria, microalbuminuria or glycosuria at baseline or during the study period. The mean urinary protein/creatinine, albumin/creatinine, α1-microglobulin/creatinine and maximal tubular phosphate reabsorption (TmPO4/GFR) ratios remained unchanged. Up to week 96, no patient experienced a significant decrease in GFR, as estimated by the more appropriate formula for age. Conclusion: Through 96 weeks, we found no evidence of impaired glomerular or tubular renal function in tenofovir-treated HIV-infected children.

AB - Background: The renal safety of tenofovir in HIV-infected children has not been well studied. In paediatrics, prediction of glomerular filtration rate (GFR) is usually obtained by the Schwartz equation; the Cockcroft-Gault equation is considered more appropriate in children aged >12 years, but can be misleading in younger children. The aims of this study were to assess renal safety and GFR changes as estimated by the Schwartz and Cockcroft-Gault equations in HIV-infected children treated with tenofovir for 96 weeks. Methods: Several parameters of glomerular and tubular function were prospectively assessed (at baseline and at weeks 24, 48, 72 and 96) in 27 HIV-infected children (aged 4.9-18.0 years) receiving a tenofovir-containing antiretroviral regimen. GFR was estimated using Schwartz and Cockcroft-Gault equations in children younger and older than 12 years, respectively. Results: No child experienced a grade 1 (≥44 μmol/L) or higher increase in serum creatinine or a grade 1 (≤0.71 mmol/L) or higher hypophosphataemia. Serum bicarbonate values were in the normal range for age at baseline. Mean serum creatinine, serum phosphorus and serum bicarbonate values remained unchanged. No child showed proteinuria, microalbuminuria or glycosuria at baseline or during the study period. The mean urinary protein/creatinine, albumin/creatinine, α1-microglobulin/creatinine and maximal tubular phosphate reabsorption (TmPO4/GFR) ratios remained unchanged. Up to week 96, no patient experienced a significant decrease in GFR, as estimated by the more appropriate formula for age. Conclusion: Through 96 weeks, we found no evidence of impaired glomerular or tubular renal function in tenofovir-treated HIV-infected children.

UR - http://www.scopus.com/inward/record.url?scp=34547189266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547189266&partnerID=8YFLogxK

U2 - 10.2165/00044011-200727080-00006

DO - 10.2165/00044011-200727080-00006

M3 - Article

VL - 27

SP - 573

EP - 581

JO - Clinical Drug Investigation

JF - Clinical Drug Investigation

SN - 1173-2563

IS - 8

ER -